A 28-year-old nulligravid woman presents to the clinic alongside her partner, reporting an inability to conceive after 12 months of regular, unprotected intercourse. She previously experienced predictable 28-day menstrual cycles, but over the past eight months, she has had only two episodes of light vaginal bleeding. The patient notes a generalized lack of energy and an unintentional 8-kg (17.6-lb) weight gain during this period. She also reports the recent appearance of dark, coarse hair on her chin. Her body mass index is 31 kg/m . Vital signs show a heart rate of 56/min and blood pressure of 112/74 mmHg. Pelvic examination is unremarkable. Transvaginal ultrasonography reveals symmetrically enlarged ovaries, each containing 15 to 20 small subcapsular follicles.
Laboratory studies show the following:
- -hCG: negative
- Total testosterone: 65 ng/dL (Reference: 15-70 ng/dL)
- Prolactin: 48 ng/mL (Reference: < 20 ng/mL)
- Thyroid-stimulating hormone (TSH): 11.2 U/mL (Reference: 0.4-4.0 U/mL)
- Free thyroxine (T4): 0.6 ng/dL (Reference: 0.9-1.7 ng/dL)
- Follicle-stimulating hormone (FSH): 4 mIU/mL
- Luteinizing hormone (LH): 3 mIU/mL
Which of the following is the most appropriate next step in the management of this patient's infertility?
- Initiate levothyroxine supplementationAnswer
- BStart therapy with an aromatase inhibitor
- COrder neuroimaging of the sella turcica
- DPrescribe a dopamine agonist
- EMeasure early morning serum 17-hydroxyprogesterone